Now available - SARS-CoV-2 Spike RBD Variant Delta
Publication date : 2021-07-27
Developed in our laboratories in Besançon (France)
#715-H25-0BU SARS-CoV-2 Spike RBD Variant Delta Lineage B.1.617.2
Excellence in monoclonal antibody and immunoassay development
Focus on...
Discover Diaclone
With over 30 years of experience and expertise, high quality has become the hallmark of the Diaclone Immunology products, firmly establishing us as a centre of excellence in Monoclonal Antibody research and Immunoassay Kit development.
Our experience and expertise coupled to the diversity and quality of our product range makes Diaclone a clear choice to Fast Track Your Research.
The expanding range of Diaclone immunology products is specifically designed for key research in clinical and preclinical applications by the pharmaceutical industry, biotechnology and diagnostic companies but also by public research laboratories in France and internationally.
Product types
Monoclonal Antibodies: unconjugated, labelled or azide free formats.
Immunoassays ELISA and ELISpot: pair, set and kit formats, ELISpot mono or dual
Recombinant proteins: Human Interleukins, SARS-CoV-2 and other targets under development
Standard catalogue and bulk sizes on request
The major research fields
Immunotherapy & Cancer - Vaccinology - Inflammation - Allergy - Autoimmune diseases - Apoptosis ...
The main applications
CD markers, Cytokine and Growth factors, TRAIL receptors, Cell adhesion molecules (CAM), In vivo controls, T-Cells…
A large range of specificities
Interleukins e.g. IL-2, IL-6, IL-8, IL-17 family…, CD markers e.g. CD138 (Syndecan), CD126…, IFN gamma, TNF alpha, Perforin, Granzyme, Isotype controls…
Target species: human, murine, rat, porcine…
The Diaclone service
Products developed in our own laboratories by experts in immunology, for a high-quality service, deliveries within 48 hours, and direct technical and scientific assistance
Diaclone is based in Besançon, France and is a member of the mAbexperts group (Biotech Investissement holding), a group of companies who collectively provide an expert synergy in the field of monoclonal antibodies, with highly experimented teams of researchers in their laboratories.
- Monoclonal Antibodies
- Antibody
- Biologically Active
- Capture
- Detection
- Isotype Control
- Recombinant Antibody
- SARS-CoV-2
- Recombinant Proteins
- SARS-CoV-2
- Cytokine
- Recombinant Protein
- Apoptosis
- B Cell Antigens
- Cancer Marker
- CD Markers
- Cell Adhesion
- CK/CC receptors
- Cytokines / Growth Factors
- Cytotoxic Molecules
- Endothelial Cells
- Epitope Tags
- Innate Immunity
- Isotype Control
- Misc
- Myeloid Cells
- NK Cells
- Non Lineage Markers
- Platelets
- SARS-CoV-2 (COVID-19)
- Soluble Antigens
- T Cells
- Tetraspanin
- c-Myc
- CD10
- CD102
- CD102 / ICAM-2
- CD105
- CD106
- CD106 / VCAM-1
- CD107a
- CD109
- CD112
- CD116
- CD117
- CD117 / c-kit
- CD11a
- CD11a / LFA-1
- CD11b
- CD11b / MAC-1
- CD11c
- CD11c / Integrin a X
- CD123
- CD124
- CD126
- CD126 / IL-6R
- CD13
- CD130
- CD130 / gp130
- CD138
- CD138 / Syndecan-1
- CD14
- CD141
- CD141 / Thrombomodulin
- CD146
- CD15
- CD151
- CD151 / TA-3
- CD154
- CD154 / CD40L
- CD16
- CD161
- CD178
- CD178/FasL
- CD18
- CD184
- CD19
- CD196
- CD1a
- CD1b/c
- CD2
- CD2 / LFA-2
- CD20
- CD202b / Tie-2 / TEK
- CD21
- CD213a1
- CD213a1 / IL-13Ra1
- CD213a2
- CD213a2 / IL-13Ra2
- CD22
- CD23
- CD25
- CD25 / IL-2R
- CD27
- CD28
- CD29
- CD3
- CD30
- CD31
- CD31 / PECAM-1
- CD33
- CD34 Class I
- CD34 Class I
- CD34 Class III
- CD35
- CD36
- CD38
- CD4
- CD40
- CD40L
- CD41
- CD41a
- CD41a / GPIIIb
- CD42b
- CD42b / GPIb
- CD43
- CD44
- CD44 / PGP-1
- CD45
- CD45RA
- CD45RO
- CD48
- CD48 / BLAST-1
- CD49d
- CD5
- CD50
- CD53
- CD54
- CD54 / ICAM-1
- CD55
- CD56
- CD56 / NCAM
- CD57
- CD58
- CD59
- CD6
- CD61
- CD61 / GPIIIa
- CD62E
- CD62E / E-Selectin
- CD62L
- CD62L / L-Selectin
- CD62P
- CD62P / P-Selectin
- CD63
- CD64
- CD66a
- CD7
- CD71
- CD75
- CD8
- CD80
- CD80 / B7 / BB1
- CD81
- CD82
- CD86
- CD9
- CD94
- CD95
- CD95 / FAS
- CD99
- Cytochrome C
- I-TAC
- IFN alpha 2a
- IFN-γ
- IL-10
- IL-12
- IL-12p35+p70
- IL-12p40
- IL-12p40+p70
- IL-12p70
- IL-13
- IL-15
- IL-17A
- IL-17A/F
- IL-17B
- IL-17C
- IL-17F
- IL-18Ra
- IL-18Rb
- IL-1α
- IL-1β
- IL-2
- IL-21
- IL-22
- IL-23
- IL-23 p19
- IL-24
- IL-24 / MDA-7 / Th2-specific cytokine FISP
- IL-27
- IL-28A
- IL-28B
- IL-29
- IL-31
- IL-32
- IL-33
- IL-34
- IL-35
- IL-37
- IL-4
- IL-5
- IL-6
- IL-7
- IL-8
- IL1RAP
- IP-10
- Isotype Control
Medix Biochemica expands its monoclonal antibody offering through the acquisition of Diaclone
Publication date : 2021-07-13
Medix Biochemica has acquired 100 percent of the shares of Diaclone, a prominent provider of monoclonal antibodies in the areas of inflammation, oncology and immunology.